Role of intraocular injection of antibiotic Moxifloxacin during cataract surgery for prevention of post-cataract surgery infectio
Phase 4
- Conditions
- Health Condition 1: null- CataractHealth Condition 2: H259- Unspecified age-related cataract
- Registration Number
- CTRI/2018/04/013149
- Lead Sponsor
- CIPLA Pharmaceuticals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a. Patients with senile cataract undergoing phacoemulsification
b. Age > 40 years
c. Patient willing for follow up
Exclusion Criteria
a. Complicated cataract
b. Previous intraocular surgery
c. Age < 40 years
d. Adnexal infections/ Active blepharitis/ Atopic keratoconjunctivitis
f. Patients not willing for follow-up
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of endophthalmitisTimepoint: preoperative <br/ ><br>post operative 1 day, 1 week, 3 weeks and 6 weeks
- Secondary Outcome Measures
Name Time Method 1.UDVA <br/ ><br>2.BCVA <br/ ><br>3.Intraocular Pressure <br/ ><br>4.central corneal thickness <br/ ><br>5.Endothelial cell density <br/ ><br>6.Central macular thickness (OCT) <br/ ><br>7.Vitreous haze <br/ ><br> <br/ ><br>Timepoint: preoperative <br/ ><br>post operative 1 day, 1 week, 3 weeks and 6 weeks